Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$6.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 10 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Jul 2 | ANIP | Ani Pharmaceuticals INC | MEXER◷◆ | 3,313 | $49.51 | $164K | — | Open the original filing on SEC.gov |
| Jul 2 | ANIP | Ani Pharmaceuticals INC | SSELL◷ | 3,313 | $86.00 | $284.9K | -1.8% | Open the original filing on SEC.gov |
| Jul 2 | ANIP | Ani Pharmaceuticals INC | MEXER◷ | 3,313 | $49.51 | $164K | +1.9% | Open the original filing on SEC.gov |
| Jun 29 | ANIP | Ani Pharmaceuticals INC | SSELL◷ | 2,850 | $84.12 | $239.7K | -1.6% | Open the original filing on SEC.gov |
| Jun 5 | ANIP | Ani Pharmaceuticals INC | MEXER◷◆ | 3,312 | $49.51 | $164K | — | Open the original filing on SEC.gov |
| Jun 5 | ANIP | Ani Pharmaceuticals INC | SSELL◷ | 3,312 | $80.00 | $265K | -1.8% | Open the original filing on SEC.gov |
| Jun 5 | ANIP | Ani Pharmaceuticals INC | MEXER◷ | 3,312 | $49.51 | $164K | +1.8% | Open the original filing on SEC.gov |
| Mar 7 | ANIP | Ani Pharmaceuticals INC | FTAX | 5,150 | $74.04 | $381.3K | -2.8% | Open the original filing on SEC.gov |
| Mar 5 | ANIP | Ani Pharmaceuticals INC | MEXER◆ | 3,312 | $49.51 | $164K | — | Open the original filing on SEC.gov |
| Mar 5 | ANIP | Ani Pharmaceuticals INC | SSELL | 4,000 | $75.56 | $302.2K | -2.1% | Open the original filing on SEC.gov |
| Mar 5 | ANIP | Ani Pharmaceuticals INC | SSELL | 3,312 | $75.42 | $249.8K | -1.7% | Open the original filing on SEC.gov |
| Mar 5 | ANIP | Ani Pharmaceuticals INC | MEXER | 3,312 | $49.51 | $164K | +1.8% | Open the original filing on SEC.gov |
| Feb 28 | ANIP | Ani Pharmaceuticals INC | FTAX | 2,773 | $73.90 | $204.9K | -1.4% | Open the original filing on SEC.gov |
| Feb 26 | ANIP | Ani Pharmaceuticals INC | AGRANT | 22,233 | $77.15 | $1.7M | +13.1% | Open the original filing on SEC.gov |
| Feb 14 | ANIP | Ani Pharmaceuticals INC | FTAX | 2,448 | $77.36 | $189.4K | -1.4% | Open the original filing on SEC.gov |
| Feb 12 | ANIP | Ani Pharmaceuticals INC | FTAX | 2,829 | $76.70 | $217K | -1.6% | Open the original filing on SEC.gov |
| Feb 11 | ANIP | Ani Pharmaceuticals INC | FTAX | 5,503 | $76.25 | $419.6K | -3.0% | Open the original filing on SEC.gov |
| Aug 12, 2025 | ANIP | Ani Pharmaceuticals INC | MEXER◆ | 50,000 | $46.49 | $2.3M | — | Open the original filing on SEC.gov |
| Aug 12, 2025 | ANIP | Ani Pharmaceuticals INC | SSELL | 50,000 | $86.07 | $4.3M | -21.7% | Open the original filing on SEC.gov |
| Aug 12, 2025 | ANIP | Ani Pharmaceuticals INC | MEXER | 50,000 | $46.49 | $2.3M | +27.7% | Open the original filing on SEC.gov |